It also suggested a lower mortality rate of 8% in the remdesivir group compared to 11.6% in the placebo group but did not reach statistical significance ( p = 0.059) ( 167 , 168 ).
← all excerpts
Clinical Characteristics, Diagnosis, and Treatment of Major Coronavirus Outbreaks.
1
0.0590
0.0590